The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells
Open accessPublished version of a preprint
The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Background: P-glycoprotein (P-gp), a member of the ATP Binding Cassette B1 subfamily (ABCB1), confers resistance to clinically relevant anticancer drugs and targeted chemotherapeutics. However, paradoxically P-glycoprotein overexpressing drug resistant cells are “collaterally sensitive” to non-toxic drugs that stimulate its ATPase activity. Methods: Cell viability assays were used to determine the effect of low concentrations of tamoxifen on the proliferation of multidrug resistant cells (CHO R C5 and MDA-Doxo 400 ), expressing P-gp, their parental cell lines (AuxB1 and MDA-MB-231) or P-gp-CRISPR knockout clones of AuxB1 and CHO R C5 cells. Western blot analysis was used to estimate P-gp expression in different cell lines. Apoptosis of tamoxifen-induced cell death was estimated by flow cytometry using Annexin-V-FITC stained cells. Oxidative stress of tamoxifen treated cells was determined by measuring levels of reactive oxygen species and reduced thiols using cell-permeant 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA) and 5,5-dithio-bis-(2-nitrobenzoic acid) DTNB, respectively. Results: In this report, we show that P-gp-expressing drug resistant cells (CHO R C5 and MDA-Doxo 400 ) are collaterally sensitive to the anti-estrogen tamoxifen or its metabolite (4-hydroxy-tamoxifen). Moreover, P-gp-knockout clones of CHO R C5 cells display complete reversal of collateral sensitivity to tamoxifen. Drug resistant cells exposed to low concentrations of tamoxifen show significant rise in reactive oxygen species, drop of reduced cellular thiols and increased apoptosis. Consistent with the latter, CHO R C5 cells expressing high levels of human Bcl-2 (CHO R C5-Bcl-2) show significant resistance to tamoxifen. In addition, the presence of the antioxidant N-acetylcysteine or P-gp ATPase inhibitor, PSC-833, reverse the collateral sensitivity of resistant cells to tamoxifen. By contrast, the presence of rotenone (specific inhibitor of mitochondria complex I) synergizes with tamoxifen. Conclusion: This study demonstrates the use of tamoxifen as collateral sensitivity drug that can preferentially target multidrug resistant cells expressing P-gp at clinically achievable concentrations. Given the widespread use of tamoxifen in the treatment of estrogen receptor-positive breast cancers, this property of tamoxifen may have clinical applications in treatment of P-gp-positive drug resistant breast tumors. Graphical Abstract:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Overexpression of epidermal growth factor receptor (EGFR), variations in TAM metabolism, and increased expression of drug-resistant proteins (P-glycoprotein, P-gp) all contribute to the development of TAM-resistant breast cancer.”
From Multifunctional and dual-targeting polymeric prodrug nanomicelles against tamoxifen-resistant breast cancer (2026) · cites this paper as [20]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proceedings of the National Academy of Sciences of the United States of America
Dowling, J. E., & Wald, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06752.x · Cited by 17,893
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178 · cited 1×
“To assess the combined effects of different drugs, and measure potential drug synergy on cell proliferation, the method of Chou-Talay was used [25].”
MethodBiochemical and Biophysical Research Communications
(1960) · Nature · doi:10.1038/186124d0 · Cited by 6,700
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Antimicrobial agents and chemotherapy—1969
Parker, R. H. (1971) · Journal of Chronic Diseases · doi:10.1016/0021-9681(71)90113-5 · Cited by 2,504
Synergy, antagonism, and what the chequerboard puts between them
Odds, F. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg301 · Cited by 2,481
THE JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
(1975) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1975.tb105896.x · Cited by 1,899
Carter, H. E., Bhattacharyya, P. K., Weidman, K. R., & Fraenkel, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06727.x · Cited by 1,896
Tamoxifen in the Treatment of Breast Cancer
Osborne, C. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811263392207 · Cited by 1,320
P-glycoprotein: from genomics to mechanism
Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E., & Gottesman, M. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206948 · Cited by 1,074 · cited 1×
“P-glycoprotein (P-gp or ABCB1), a member of a large family of ATP Binding Cassette (ABC) transporters, mediates the active efflux of anticancer drugs [4].”
Background
Cited by
Berberine: Potential preventive and therapeutic strategies for human colorectal cancer
Feng, Y., Lu, J., Jiang, J., Wang, M., Guo, K., & Lin, S. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4033 · Cited by 24
“94 The expression and function of P ‐ gp is related to the occurrence and development of IBD.”
BackgroundNguyen, H. M., Nguyen, T. Y. N., Le, N. T. H., Le, T. N. T., Chau, N. T. N., Le, T. M. H., & Nguyen, B. Q. H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39229 · Cited by 24
“The prevention development of breast cancer cell tamoxifen resistance through probably inhibited P-gp expression was reported [107].”
BackgroundMansour, E., Abdrabou, A., Zaghlool, S. S., Sayed, A. M., Nassar, I. F., & Elewa, S. I. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.141471 · Cited by 12
The role of ABC-transporters in homeostasis, cancer pathogenesis and therapy
Boichuk, S., & Ivoilova, T. V. (2024) · Advances in molecular oncology · doi:10.17650/2313-805x-2024-11-1-8-21 · Cited by 7
Kim, S. G., Kim, S. J., Duong, T. V., Cho, Y., Park, B., Kadam, U. S., Park, H. S., & Hong, J. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111714 · Cited by 4
Retracted
Metadata
- Authors
- Bakadlag, R., Limniatis, G., Georges, G., & Georges, E.
- Affiliations
- Collège MacDonald (CA)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Corresponding author
- Georges, Elias
- Venue
- BMC Cancer
- Published
- 2023-01-06
- Volume
- 23
- Issue
- 1
- Pages
- 24-24
- ISSN
- 1471-2407 (ISSN-L)
- PMC
- PMC9824978
- OpenAlex
- W4313613090
- Cited by
- 9
- References
- 64
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 5
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- BMC Cancer (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Natural Sciences and Engineering Research Council of Canada (2017-05009)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- tamoxifen, P-glycoprotein, multidrug resistance, collateral sensitivity, 4-hydroxytamoxifen, reactive oxygen species, oxidative stress, apoptosis, Bcl-2, PSC833, N-acetylcysteine, rotenone, mitochondrial complex I
- MeSH terms
- Adenosine Triphosphatases, Humans, Receptors, Estrogen, Tamoxifen, Reactive Oxygen Species, Drug Resistance, Multiple, ATP Binding Cassette Transporter, Subfamily B, Drug Resistance, Neoplasm, Proto-Oncogene Proteins c-bcl-2, ATP Binding Cassette Transporter, Subfamily B, Member 1, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells. https://app.cochat.ai/papers/10.1186/s12885-022-10474-x
- The paper
- Bakadlag, R., Limniatis, G., Georges, G., & Georges, E. (2023). The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells. BMC Cancer. https://doi.org/10.1186/s12885-022-10474-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.